T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Cable One
CABO
$206M
| $133M | 0.03% |
+317,138
| New | +$131M |
|
|
ELME
502
Elme Communities
ELME
$144M
| $133M | 0.03% |
5,331,360
-462,340
| -8% | -$11.9M |
|
|
BKI
503
DELISTED
Black Knight, Inc. Common Stock
BKI
| $133M | 0.03% |
4,070,872
+2,029,872
| +99% | +$65.7M |
|
|
DCT
504
DELISTED
DCT Industrial Trust Inc.
DCT
| $132M | 0.03% |
3,934,264
+40,270
| +1% | +$1.35M |
|
505
Shutterstock
SSTK
$217M
| $132M | 0.03% |
4,378,243
+793,405
| +22% | +$31.9M |
|
506
Trimble
TRMB
$13.4B
| $132M | 0.03% |
8,052,654
-10,965,360
| -58% | -$221M |
|
|
LVNTA
507
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $132M | 0.03% |
3,260,347
+2,616,528
| +406% | +$106M |
|
|
SCHW
508
Charles Schwab
SCHW
$190B
| $131M | 0.03% |
4,598,502
-2,283,365
| -33% | -$73.3M |
|
509
Ultragenyx Pharmaceutical
RARE
$2.6B
| $131M | 0.03% |
1,358,955
+179,815
| +15% | +$20.6M |
|
|
EPAY
510
DELISTED
Bottomline Technologies Inc
EPAY
| $131M | 0.03% |
5,222,460
+91,200
| +2% | +$2.43M |
|
511
Puma Biotechnology
PBYI
$450M
| $130M | 0.03% |
1,730,703
-363,744
| -17% | -$34.4M |
|
512
Infosys
INFY
$50.3B
| $129M | 0.03% |
13,493,438
-1,771,646
| -12% | -$15.2M |
|
513
Nordson
NDSN
$17.3B
| $128M | 0.03% |
2,032,410
-797,250
| -28% | -$56M |
|
|
DPLO
514
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $127M | 0.03% |
4,430,033
-108,268
| -2% | -$4.63M |
|
515
Teledyne Technologies
TDY
$31.2B
| $127M | 0.03% |
1,402,823
+36,580
| +3% | +$3.7M |
|
|
BHI
516
DELISTED
Baker Hughes
BHI
| $126M | 0.03% |
2,424,822
-681,385
| -22% | -$38.1M |
|
517
Assured Guaranty
AGO
$3.35B
| $126M | 0.03% |
5,037,261
+11,630
| +0.2% | +$293K |
|
|
AVNS
518
DELISTED
Avanos Medical
AVNS
| $125M | 0.03% |
4,412,390
+110,630
| +3% | +$3.86M |
|
519
Cognex
CGNX
$10.4B
| $124M | 0.03% |
7,225,472
+2,740,322
| +61% | +$54.4M |
|
520
ScottsMiracle-Gro
SMG
$3.59B
| $121M | 0.03% |
1,992,689
-98,350
| -5% | -$6.07M |
|
|
SBNY
521
DELISTED
Signature Bank
SBNY
| $121M | 0.03% |
879,147
-836,887
| -49% | -$118M |
|
522
Adtran
ADTN
$658M
| $119M | 0.03% |
8,179,648
+85,900
| +1% | +$1.36M |
|
523
Pebblebrook Hotel Trust
PEB
$2.05B
| $119M | 0.03% |
3,346,412
-23,690
| -0.7% | -$951K |
|
524
Westamerica Bancorp
WABC
$1.39B
| $116M | 0.03% |
2,619,878
-600
| -0% | -$28.5K |
|
525
DTE Energy
DTE
$29B
| $116M | 0.03% |
1,699,242
-59,032
| -3% | -$3.95M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.